Salix Pharmaceuticals and Cosmo Pharmaceuticals have called off their $2.7 billion merger, citing recent moves by the U.S. Treasury Department to make it more difficult for companies to complete ...

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the opening of the 2025 Salix Gastrointestinal Health Scholars ...

Oct 3 (Reuters) - Salix Pharmaceuticals Ltd and Cosmo Pharmaceuticals SpA said they have terminated their merger agreement, citing a "changed political environment". Raleigh, North Carolina-based ...

We’ll send you a myFT Daily Digest email rounding up the latest Valeant news every morning. If Mike Pearson, chief executive of Valeant Pharmaceuticals, wants to pay more than necessary to clinch a ...

Simply sign up to the Currencies myFT Digest -- delivered directly to your inbox. Valeant was moving ahead with the sale of $9.6bn worth of bonds to fund the acquisition of Salix despite growing ...